Congratulations to Dr. Andrea Cercek, a gastrointestinal oncologist at MSK, who was named to the inaugural 2024 TIME 100 Health, a new annual list of 100 individuals who most influenced global health this year. #TIME100Health

In the last 10 years, Tom has led the field and transformed the care of bladder and kidney cancer patients. Very happy to call him a friend and colleague. Congratulations Tom Powles !

This May is #BladderCancerMonth24 and watch out for our weekly podcast on our website this Friday with our special guest Jonathan Rosenberg MD who gives updates in ADCs including:

⭐The future of EV + pembro
⭐SG + other ADCs
⭐Managing toxicities

Here's a 30 sec preview 🎙️

#blcsm

Well, the Dana-Farber Lank Center for Genitourinary Oncology is hiring again:

Apply at:
nejmcareercenter.org/job/760635/gen…

The power of the cooperative groups! - Stephanie Berg
Alliance for Clinical Trials in Oncology Toni Choueiri, MD Tian Zhang, MD, MHS Dan George Michael Morris Matt Galsky Jonathan Rosenberg MD
oncodaily.com/56060.html

#ClinicalTrials #Cancer #GenitourinaryOncology #OncoDaily #Oncology

Looking forward to presenting prelim results of our phase 1 study of intravesical Fc-engineered anti-CD40 agonistic antibody in NMIBC at AACR. Amazing MSK/RU collaboration led by @bbmdms Jonathan Rosenberg MD moving from the bench to the clinic! #AACR24
abstractsonline.com/pp8/#!/20272/p…

Together with Alliance for Clinical Trials in Oncology, we're pleased to announce the the launch of Alliance A032103 (MODERN), a randomized, phase II/III, biomarker-integrated trial. ow.ly/ihAF50R5IT8

Very happy to see this in print! Congratulations to all involved in this transformative effort, and to the patients who may benefit from this combination therapy.

This trial will answer several important questions- do we need to escalate therapy to get better outcomes in the highest risk patients, and can we de-escalate in those who are lower risk. Matt Galsky Andrea Apolo, M.D. Tom Powles Guru P. Sonpavde, MD Tian Zhang, MD, MHS

EV301👉HRQoL with EV was maintained, and deterioration in HRQoL was delayed with EV in comparison to chemotherapy. 👉Better results with EV were reported for some scales ⁦Jonathan Rosenberg MD⁩ ⁦Tom Powles⁩ europeanurology.com/article/S0302-…

We have a two year position for early career investigator focused on gastroesophageal cancer.
Details below
careers.mskcc.org/vacancies/2024…

Exciting risk-adapted trial for adjuvant therapy in urothelial cancer. Able to be opened across the NCTN program!

Big news for bladder cancer in US!
“On December 15, 2023, the Food and Drug Administration (FDA) approved enfortumab vedotin-ejfv in combination with pembrolizumab for patients with locally advanced or metastatic urothelial cancer (la/mUC).”

Can’t agree more!

Very excited to announce our work on understanding the contributions of Fc gamma receptors (FcgR) to the antitumor activity of CD47 antibodies, and Fc-engineering as a strategy to enhanced the activity of this immunotherapy. Out today in
Cancer Cell:
cell.com/cancer-cell/fu…

Lots of great candidates that i am fortunate to know personally, including Dr. Small, Dr. Rathmell, and, of course my great friend and former colleague, Toni Choueiri, MD. Its a great opportunity for GU Oncology to have so many outstanding candidates.
old-prod.asco.org/about-asco/asc…

Congratulations to Dr. Guercio- I look forward to continuing our collaborations!
kidneycancer.org/stories/qa-bre…

Congratulations to Dr. Carlo- very well deserved!
kidneycancer.org/stories/qa-mar…

Voting for the ASCO Election is now open. I am honored to be running as one of the candidates for the Board of Directors Undesignated Member seats.

Visit asco.org/election to learn more about the candidates and place your votes!

ASCO OncoAlert Oncology Brothers Dana-Farber

Post #ESMO23 (and pre #SABCS23 #ASH23 ) we have to digest a lot of data! Join us for 3 days of CME with Benjamin Levy Jonathan Rosenberg MD Joshua Sabari, MD Stephen V Liu, MD Komal Jhaveri Amer Zeidan MBBS,MHS ‏عامر زيدان

Going to take some📝 from Aaron Goodman - “Papa Heme” and Mark Lewis for Social Media advantages.